Siregar G, Paramesh R, Kumawat R, D P, HA S. A prospective, interventional clinical study to evaluate the safety and efficacy of Liv.52 DS in the management of non-alcoholic fatty liver disease. Eur J Clin Exp Med [Internet]. 2021 Jun. 30 [cited 2026 Jan. 18];19(2):129–136. Available from: https://journals.ur.edu.pl/ejcem/article/view/11885